Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Injections × CNS × Clear all

Phase

Status

Recruiting 4 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 13 Other solid neoplasm 5 Myeloid 5 Thoracic 4 Lymphoid 4 Breast 3 Tumor-Agnostic 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1 CNS 1

Conditions

Glioma 1 Glioblastoma 1

Interventions

Temozolomide 55 Radiotherapy 32 Magnetic Resonance Spectroscopy 31 Radiosurgery 24 Specimen Handling 21 Cyclophosphamide 21 Nivolumab 20 pembrolizumab 17 Radiation 16 Carboplatin 12 Bevacizumab 12 Biopsy 11 Ipilimumab 10 Cisplatin 10 Vincristine 9 Irinotecan 9 trametinib 8 Immunoglobulin G 8 Etoposide 8 dinutuximab 7 X-Rays 7 Topotecan 7 Lomustine 7 Disulfides 7 AZD 6244 7 sargramostim 6 olaparib 6 atezolizumab 6 Granulocyte-Macrophage Colony-Stimulating Factor 6 CTLA-4 Antigen 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04808245 2025-09-22

INTERCEPT-H3

German Cancer Research Center

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡